المستودع الرقمي العراقي
Iraqi Digital Repository
تجربة المرضى مع العلاجات البيولوجية الوريدية للمرضى العراقيين المصابين بامراض المفاصل == Patients Experience with Intravenous Biologic Therapies in Iraqi Patients with Rheumatologic Diseases
اسم المؤلف:
ندى علي محمد
اسم المشرف:
زياد شفيق الراوي
الموضوع العام:
الطب
السنة:
2018
الموضوع الدقيق:
الامراض - المفاصل
الدرجة:
دبلوم عالي
الجامعة:
جامعة بغداد - كلية الطب
اللغة:
الانكليزية
مكان الجامعة:
بغداد
الصفحات الاولى:
📎 19T1391 - p.pdf
المستخلص:
Intravenous and subcutaneous administration of biologic agents differs not only in routes of administration but also in dosing schedules, costs, onset of efficacy, and immunogenicity which are associated with patients‟ preferences and corresponding persistence in treatment utilization. Additionally, injection issues (depending on route of administration and agent type) have been shown to influence patients‟ utilization of biologic therapies.ObjectiveThe main objective of this study was to describe patients experience with intravenous (IV) biologics for specific rheumatologic conditions including rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis. Patients and Methods A cross - sectional study was conducted through interviews of 196 patients with the above mentioned autoimmune diseases who were currently receiving an IV biologics at Baghdad Teaching Hospital. Patients were asked to describe the advantages and disadvantages associated with their IV infusion experience. ResultsOn a 7 - point Likert scale (1= not at all satisfied; 7= very satisfied), 90.3% of patients rated satisfaction as 5, 6 or 7. The most frequently perceived benefit of IV therapy were related to Infusion center visits which act as an additional assessment to a regular doctor visit which was equals to 88.8% of patients. Fifty one percent of patientsexperienced t “No disadvantage” in receiving IV biologic therapy and 25% of patients reported that the duration of infusion takes too long as perceived disadvantages. The two most common reasons for preferring IV therapy were the less frequent dosing regimenreported by 81.6 % of patients and 54.1% of patients believes that the intravenous infusion was always effective and they have no experience with subcutaneous therapy.ConclusionsPatients using IV biologics are highly satisfied with their medications and their preferences are due to less frequent dosing, the perceived IV injection effectiveness and the easier to remember dosing when an appointment is scheduled for them.
مشاركة البيانات
Share Data